Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Neuroectodermal Tumors × Radiotherapy × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 25 Carcinoma, Non-Small-Cell Lung 25 Lung Neoplasms 21 Head and Neck Neoplasms 16 Gliosarcoma 14 Squamous Cell Carcinoma of Head and Neck 12 Lymphoma 11 Central Nervous System Neoplasms 11 Sarcoma 10 Glioma 10 Esophageal Neoplasms 10 Prostatic Neoplasms 8 Pancreatic Neoplasms 7 Leukemia 7 Breast Neoplasms 7 Brain Neoplasms 7 Rectal Neoplasms 6 Esophageal Squamous Cell Carcinoma 6 Neoplasms 5 Neoplasm Metastasis 5 Melanoma 5 Adenocarcinoma of Lung 5 Uterine Cervical Neoplasms 4 Small Cell Lung Carcinoma 4 Radiation Injuries 4 Colorectal Neoplasms 4 Stomach Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Medulloblastoma 3 Carcinoma, Squamous Cell 3

Interventions

repotrectinib 1 pralsetinib 1 pamiparib 1 Vincristine 1 Temozolomide 1 Radiotherapy 1 Radiation 1 Maintenance Chemotherapy 1 Lomustine 1 Interleukin-12 1 Cisplatin 1 Afatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01614132 2020-03-31

NOA-07

University of Regensburg

Phase 1/2 Completed

Medulloblastoma, Neoplasms, Neuroectodermal Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡